Literature DB >> 20194578

Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.

Mathilde Deloire1, Aurélie Ruet, Delphine Hamel, Melissa Bonnet, Bruno Brochet.   

Abstract

Cognition is frequently impaired in the early stages of multiple sclerosis (MS). The predictive value of cognitive impairment on disability is unknown. The objective of this study was to correlate cognitive impairment and the progression of disability over 7 years. Forty-five patients, recruited after MS diagnosis, were followed for 7 years by yearly Expanded Disability Status Scale (EDSS) and Multiple Sclerosis Functional Composite (MSFC) evaluations and were classified as cognitively impaired (CI) or unimpaired (CU) according to neuropsychological testing at baseline. At baseline, 47.8% of patients were CI, with deficits in mainly memory and information processing speed (IPS). The baseline EDSS correlated significantly with one IPS test. The EDSS, but not the MSFC, deteriorated significantly over the 7 years in the whole group and the CI group, but not the CU group. A multivariate analysis showed correlations between the EDSS change over 5 and 7 years and two baseline tests evaluating IPS and verbal memory. The deterioration of the EDSS after 7 years was significantly correlated with verbal memory testing at baseline after adjustment for age and baseline EDSS. In conclusion, in this sample of MS patients early in the disease, the baseline IPS and verbal memory impairments predict the EDSS score 5 and 7 years later.

Entities:  

Mesh:

Year:  2010        PMID: 20194578     DOI: 10.1177/1352458510362819

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  29 in total

1.  Cognitive assessment in multiple sclerosis-an Italian consensus.

Authors:  Maria Pia Amato; Vincenzo Brescia Morra; Monica Falautano; Angelo Ghezzi; Benedetta Goretti; Francesco Patti; Alice Riccardi; Flavia Mattioli
Journal:  Neurol Sci       Date:  2018-05-15       Impact factor: 3.307

2.  Sensory evoked potentials to predict short-term progression of disability in multiple sclerosis.

Authors:  N Margaritella; L Mendozzi; M Garegnani; E Colicino; E Gilardi; L Deleonardis; F Tronci; L Pugnetti
Journal:  Neurol Sci       Date:  2011-11-27       Impact factor: 3.307

3.  Baseline characteristics and effects of fingolimod on cognitive performance in patients with relapsing-remitting multiple sclerosis.

Authors:  Dawn W Langdon; Davorka Tomic; Iris-Katharina Penner; Pasquale Calabrese; Gary Cutter; Dieter A Häring; Frank Dahlke; Ludwig Kappos
Journal:  Eur J Neurol       Date:  2021-10-12       Impact factor: 6.288

4.  The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a.

Authors:  Hanne van Ballegooijen; Karin van der Hiele; Christian Enzinger; Gert de Voer; Leo H Visser
Journal:  eNeurologicalSci       Date:  2022-06-14

Review 5.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 6.  Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.

Authors:  Timothy Vollmer; Lynn Huynh; Caroline Kelley; Philip Galebach; James Signorovitch; Allitia DiBernardo; Rahul Sasane
Journal:  Neurol Sci       Date:  2015-11-04       Impact factor: 3.307

7.  Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.

Authors:  Aurélie Ruet; Mathilde Deloire; Delphine Hamel; Jean-Christophe Ouallet; Klaus Petry; Bruno Brochet
Journal:  J Neurol       Date:  2012-10-19       Impact factor: 4.849

Review 8.  ["Time is brain" in relapsing remitting multiple sclerosis. Current treatment concepts in immunotherapy].

Authors:  R Linker; B-A Kallmann; C Kleinschnitz; P Rieckmann; M Mäurer; S Schwab
Journal:  Nervenarzt       Date:  2015-12       Impact factor: 1.214

Review 9.  Early Aggressive Treatment Approaches for Multiple Sclerosis.

Authors:  Alexandra Simpson; Ellen M Mowry; Scott D Newsome
Journal:  Curr Treat Options Neurol       Date:  2021-05-15       Impact factor: 3.598

10.  Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.

Authors:  Chris Edgar; Peter J Jongen; Evert Sanders; Christian Sindic; Sophie Goffette; Michel Dupuis; Philippe Jacquerye; Daniel Guillaume; Regine Reznik; Keith Wesnes
Journal:  BMC Neurol       Date:  2011-06-07       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.